Drug recall · August 5, 2015
Clonidine Hydrochloride Tablets recall
Why: cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA, NDC 53489-217-01
- Lots / codes
Lot #: 6676701 and 6676801, exp 1/17
- Quantity
- 20,892 bottles
- Company
- Mutual Pharmaceutical Company, Inc., Philadelphia, PA
- Distribution
- Nartionwide
- Initiated
- July 9, 2015 · Voluntary: Firm initiated
- Classified
- July 30, 2015
- Reported
- August 5, 2015
- Ended
- October 13, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.